Ireland
--:--IST
Latest
Clinical Trials in the Netherlands / NCT07070570
Starting soon Not applicable

HAKA: Routine Follow-up at 10 Years After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare?

NCT07070570 · tracked via the Priya Life Science Netherlands tracker
Phase
Not applicable
Started
2025-09-01
Last updated
2025-07-17

Condition(s) studied

Hip Arthroplasty, TotalKnee Arthroplasty, Total

Investigational drug(s) / intervention(s)

Routine Follow-Up (RFU)Active Check-Up on Demand (ACOD)Passive Check-Up on Demand (PCOD)

Routine Follow-Up (RFU): Standard follow-up care with scheduled X-ray, clinical visit and questionnaires at 10 years after surgery

Active Check-Up on Demand (ACOD): X-ray, clinical visit and questionnaires at 10 years after surgery when requested by the patient or healthcare provider.

Passive Check-Up on Demand (PCOD): X-ray and clinical visit (without questionnaires) at 10 year when requested by the patient or healthcare provider.

Study summary

After undergoing total hip or total knee arthroplasty, current guidelines recommend routine follow-up with an X-ray within 3 months and again at 1 year. Follow-up at 5 years (for hip arthroplasties) or every 5 years (for knee arthroplasties) is also considered worthwhile according to the guideline. However, these follow-up appointments require considerable time from patients, caregivers, and healthcare professionals, and it is unclear whether they are truly beneficial. It is possible that a single follow-up within 3 months is sufficient. This could potentially prevent over 100,000 unnecessary hospital visits per year, resulting in significant cost savings. If patients or healthcare providers have concerns, they can always request an additional follow-up.

The HAKA trial consists of three different work packages (WPs). This trial (WP2) investigates the 10-year follow-up, WP1 examines the 1-year follow-up, and WP3 is a qualitative study exploring the experiences and perceptions of patients and healthcare professionals. The aim of the HAKA trial is to safely reduce routine follow-up appointments after total hip or knee arthroplasty and to revise current clinical guidelines accordingly.

Eligibility

Sex
ALL
Min age
50 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Underwent primary THA or TKA approximately 10 years ago * Age 50 years or older at time of THA or TKA * Capable and willing to complete questionnaires (when applicable) * Understanding Dutch or English * Willing to provide written informed consent in case the patient will complete questionnaires Exclusion Criteria: * Other indication for surgery than osteoarthritis * Deceased * Revision arthroplasty of hip or knee, except a conversion from unicompartmental knee arthroplasty to TKA or from hip hemiarthroplasty/resurfacing to THA * Already participating in this study due to another hip or knee surgery

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Reinier Haga Orthopedisch Centrum Zoetermeer South Holland

More Reinier Haga Orthopedisch Centrum trials in the Netherlands

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07070570 on ClinicalTrials.gov ↗ ← All trials in the Netherlands